Surface Oncology Inc. [NASDAQ: SURF] closed the trading session at $5.63 on 08/04/20. The day’s price range saw the stock hit a low of $5.23, while the highest price level was $6.27. The company report on May 28, 2020 that Surface Oncology Announces Change to Location and Format of 2020 Annual Meeting of Stockholders.
Surface Oncology (SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that its 2020 Annual Meeting of Stockholders has been changed to a virtual meeting as a result of continuing concerns surrounding the COVID-19 pandemic. The meeting will still be held on Wednesday, June 10, 2020 at 11:00 a.m. EDT, as previously announced. Stockholders will only be able to participate in this year’s Annual Meeting via the virtual meeting. This change is reflective of the public health impact of the COVID-19 pandemic, government restrictions limiting the size of gatherings, and supporting the health and well-being of Surface Oncology’s stockholders, directors and employees, and their communities.
Stockholders are entitled to participate in and vote at the Annual Meeting if they were a stockholder at the close of business on April 15, 2020, the record date, or hold a legal proxy for the meeting provided by the stockholder’s bank, broker or nominee as of such record date. To access, participate in and vote at the Annual Meeting, stockholders must register in advance at the Meeting Registration Website (https://viewproxy.com/SurfaceOncology/2020) prior to the deadline of 11:59 p.m. EDT on June 8, 2020. Upon completing registration, eligible participants will receive further instructions via email, including unique links that will allow such eligible participants to access the meeting. Eligible participants who have difficulty accessing the virtual meeting or the Meeting Registration Website may call the technical support number provided. .
The stocks have a year to date performance of 199.47 percent and weekly performance of 9.53 percent. The stock has been moved at 79.87 percent over the last six months. The stock has performed -7.86 percent around the most recent 30 days and changed 111.65 percent over the most recent 3-months.
If compared to the average trading volume of 2.30M shares, SURF reached to a volume of 1215744 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Surface Oncology Inc. [SURF]:
Robert W. Baird have made an estimate for Surface Oncology Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on September 19, 2018. While these analysts kept the previous recommendation, Goldman raised their target price to Neutral. The new note on the price target was released on May 14, 2018, representing the official price target for Surface Oncology Inc. stock. Previously, the target price had yet another raise to $26, while Evercore ISI analysts kept a Outperform rating on SURF stock.
The Average True Range (ATR) for Surface Oncology Inc. is set at 0.60, with the Price to Sales ratio for SURF stock in the period of the last 12 months amounting to 4.14. The Price to Book ratio for the last quarter was 1.93, with the Price to Cash per share for the same quarter was set at 3.10.
SURF stock trade performance evaluation
Surface Oncology Inc. [SURF] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 9.53. With this latest performance, SURF shares dropped by -7.86% in over the last four-week period, additionally plugging by 79.87% over the last 6 months – not to mention a rise of 173.30% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SURF stock in for the last two-week period is set at 53.42, with the RSI for the last a single of trading hit 55.69, and the three-weeks RSI is set at 54.26 for Surface Oncology Inc. [SURF]. The present Moving Average for the last 50 days of trading for this stock 5.24, while it was recorded at 5.29 for the last single week of trading, and 3.08 for the last 200 days.
Surface Oncology Inc. [SURF]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Surface Oncology Inc. [SURF] shares currently have an operating margin of -373.48. Surface Oncology Inc.’s Net Margin is presently recorded at -356.70.
Return on Total Capital for SURF is now -62.16, given the latest momentum, and Return on Invested Capital for the company is -60.34. Return on Equity for this stock declined to -68.69, with Return on Assets sitting at -35.84. When it comes to the capital structure of this company, Surface Oncology Inc. [SURF] has a Total Debt to Total Equity ratio set at 44.19. Additionally, SURF Total Debt to Total Capital is recorded at 30.65, with Total Debt to Total Assets ending up at 19.01. Long-Term Debt to Equity for the company is recorded at 38.96, with the Long-Term Debt to Total Capital now at 27.02.
Reflecting on the efficiency of the workforce at the company, Surface Oncology Inc. [SURF] managed to generate an average of -$1,118,143 per employee. Receivables Turnover for the company is 46.62 with a Total Asset Turnover recorded at a value of 0.10.Surface Oncology Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.00 and a Current Ratio set at 7.00.
Earnings per share (EPS) analysis for Surface Oncology Inc. [SURF] stock
With the latest financial reports released by the company, Surface Oncology Inc. posted -0.64/share EPS, while the average EPS was predicted by analysts to be reported at -0.61/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -4.90%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SURF.
Surface Oncology Inc. [SURF]: Insider Ownership positions
There are presently around $77 million, or 91.90% of SURF stock, in the hands of institutional investors. The top three institutional holders of SURF stocks are: ATLAS VENTURE ASSOCIATES IX, LLC with ownership of 4,645,453, which is approximately 0% of the company’s market cap and around 2.50% of the total institutional ownership; NEA MANAGEMENT COMPANY, LLC, holding 3,315,149 shares of the stock with an approximate value of $18.66 million in SURF stocks shares; and ECOR1 CAPITAL, LLC, currently with $7.17 million in SURF stock with ownership of nearly -2.093% of the company’s market capitalization.
Positions in Surface Oncology Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 13 institutional holders increased their position in Surface Oncology Inc. [NASDAQ:SURF] by around 311,814 shares. Additionally, 21 investors decreased positions by around 485,384 shares, while 7 investors held positions by with 12,924,487 shares. The mentioned changes placed institutional holdings at 13,721,685 shares, according to the latest SEC report filing. SURF stock had 6 new institutional investments in for a total of 84,286 shares, while 8 institutional investors sold positions of 146,252 shares during the same period.